文献速递产科母胎医学

孕中期评估小于胎龄儿风险以确定后续管理

Assessment of risk for small for gestational age at midgestation to define subsequent care.
PubMed 文献 · Am J Obstet Gynecol · 2025-06-16

本研究基于两个英国产科医院的前瞻性非干预队列,纳入134443例单胎妊娠,在孕19 0/7至23 6/7周联合母体危险因素、估计胎儿体重及子宫动脉搏动指数(三联试验)计算竞争风险模型,预测<28、<32、<36周分娩小于胎龄儿的个体风险。结果显示模型校准良好,可按目标检出率调整风险阈值和筛查阳性率。

要点

  • 孕中期三联试验可评估<28、<32、<36周分娩小于胎龄儿的个体风险。
  • 以检出约80%的<10百分位小于胎龄儿为目标,<28、<32、<36周的筛查阳性率分别为9.5%、19.6%、29.6%。
  • 队列中12.51%孕妇分娩小于胎龄儿(<10百分位),<28、<32、<36周分娩者分别占0.15%、0.42%、1.33%。

核心结论

  • 除36周常规超声外,孕中期评估小于胎龄儿分娩风险有助于识别需在26、30、33周监测的亚组。
  • 胎儿医学基金会小于胎龄儿竞争风险模型可按目标检出率和临床资源进行调整。

研究设计与样本

  • 研究队列源自英国2个产科医院的前瞻性非干预研究,纳入孕19 0/7至23 6/7周接受常规超声扫描的单胎妊娠孕妇。
  • 采用竞争风险模型,联合母体危险因素、估计胎儿体重和子宫动脉搏动指数(三联试验)估算个体风险。
  • 研究人群共134443例单胎妊娠。

主要发现

  • 其中<28、<32、<36周分娩者分别为196例(0.15%)、566例(0.42%)、1787例(1.33%)。
  • 以检出约80%的<10百分位小于胎龄儿为目标,<28、<32、<36周的筛查阳性率分别为9.5%、19.6%、29.6%。
  • 以检出约80%的<3百分位小于胎龄儿为目标,<28、<32、<36周的筛查阳性率分别为6.5%、13.0%、21.6%。
  • 校准图显示预测风险与观察到的小于胎龄儿发生率一致性良好。

关键数值与推荐

  • 不同风险阈值用于实现<28、<32、<36周分娩小于胎龄儿的80%、85%、90%检出率。
  • 计算了不同风险阈值的灵敏度、特异度、阳性预测值和阴性预测值。
  • 通过绘制观察发生率与预测发生率评估<36周分娩小于胎龄儿风险的校准。

临床怎么用

  • 孕中期评估小于胎龄儿风险可用于识别需在26、30、33周分别进行超声监测的亚组。
  • 胎儿医学基金会竞争风险模型可按目标检出率和临床资源进行调整。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have demonstrated that a competing risks model for the prediction of small-for-gestational-age neonates has a superior performance than traditional risk scoring methods. The Fetal Medicine Foundation fetal and neonatal population weight charts are derived from sonographic estimated fetal weight rather than birthweight because a large proportion of neonates born before term result from pathologic pregnancy. The individualized risk assessment for small for gestational age at midgestation could be the basis of an antenatal plan that aims to improve the management of preterm pregnancies with small for gestational age with minimum resources. OBJECTIVE: This study aimed to stratify subsequent assessments after 24 weeks of gestation based on the estimated risk of delivery of small-for-gestational-age neonates at <28, <32, and <36 weeks of gestation using the combination of maternal risk factors, with estimated fetal weight and uterine artery pulsatility index (triple test) assessed at midgestation. The rationale of the study is that pregnancies at high risk of small for gestational age at <28, <32 and <36 weeks of gestation would require ultrasound examinations at 26, 30, and 33 weeks of gestation, respectively. STUDY DESIGN: The study cohort was derived from a prospective, nonintervention study in women with singleton pregnancies attending for a routine ultrasound scan between 19 0/7 and 23 6/7 weeks of gestation in 2 United Kingdom maternity hospitals. The competing risks model was used to estimate the individual patient-specific risks of delivery of a small-for-gestational-age neonate at <36 weeks of gestation from the triple test. Different risk cutoffs were used with the intention of detecting 80%, 85%, and 90% of cases of delivery with small for gestational age at <28, <32, and <36 weeks of gestation. Discrimination measures using sensitivities, specificities, and positive and negative predictive values were computed for different risk cutoffs. The calibration of risks of delivery of small for gestational age at <36 weeks of gestation was assessed by plotting the observed incidence of small for gestational age against the predicted incidence. RESULTS: The study population of 134,443 singleton pregnancies contained 16,813 pregnant women (12.51%) who subsequently delivered small-for-gestational-age neonates with birthweights of <10th percentile, as defined by the Fetal Medicine Foundation chart, including 196 (0.15%), 566 (0.42%), and 1787 (1.33%) pregnant women who delivered at <28, <32, and <36 weeks of gestation, respectively. Using the Fetal Medicine Foundation chart to define small for gestational age, if the objective of screening was to identify approximately 80% of cases of delivery of small-for-gestational-age neonates with birthweights of <10th percentile at <28, <32, and <36 weeks of gestation, the respective screen-positive rates would be 9.5%, 19.6%, and 29.6%, respectively. Using the Fetal Medicine Foundation chart to define small for gestational age, if the objective of screening was to identify approximately 80% of cases of delivery of small-for-gestational-age neonates with birthweights of <3rd percentile at <28, <32, and <36 weeks of gestation, the respective screen-positive rates would be 6.5%, 13.0%, and 21.6%, respectively. The calibration plots demonstrated good agreement between the predicted risk and the observed incidence of small for gestational age. CONCLUSION: In addition to a routine scan at 36 weeks of gestation, assessment of the risk of birth of small-for-gestational-age neonates at midgestation is useful to identify the subgroups that require monitoring at 26, 30, and 33 weeks of gestation. The Fetal Medicine Foundation competing risks model for small for gestational age can be customized to the desired detection rate and availability of clinical resources.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Papastefanou I, Syngelaki A, Logdanidis V, et al. Assessment of risk for small for gestational age at midgestation to define subsequent care. Am J Obstet Gynecol. 2025. PMID: 40516586. doi:10.1016/j.ajog.2025.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。